NGM Biopharmaceuticals Inc (NGM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NGM Biopharmaceuticals, Inc. was notified by Nasdaq on January 18, 2024, that it has regained compliance with the minimum bid price requirement after its common stock’s closing bid price remained at $1.00 or above from January 2 to January 17, 2024. Consequently, the issue concerning its non-compliance with Nasdaq Listing Rule 5450(a)(1) has been resolved and the matter is closed.
For further insights into NGM stock, check out TipRanks’ Stock Analysis page.